Kesimpta 20 MG/0.4 ML pen 0.4ML
Ended Awarded Last action
- Contract number
- SPE2DR26FQR4H
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $31,461
Award facts
- Contract value 100% obligated
- $31,460.57 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $31,460.57 to AmerisourceBergen Drug Corp for the supply of Kesimpta (ofatumumab) 20 mg/0.4 mL auto-injector pens on December 4, 2025, with completion expected by December 5, 2025. This non-competitive delivery order utilizes firm fixed pricing and is executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 comprehensive global pharmaceutical support vehicle running through December 2026 that enables the company to supply a broad range of medications, vaccines, and medical supplies to support military healthcare programs worldwide.
Kesimpta is a specialty pharmaceutical product indicated for multiple sclerosis treatment, reflecting the critical nature of AmerisourceBergen's role in supplying specialized medications to Defense Health Agency and military healthcare systems. As a major pharmaceutical distributor and healthcare solutions provider with an extensive portfolio of federal contract awards, AmerisourceBergen consistently delivers diverse pharmaceutical commodities including brand-name and generic medications, neurological treatments, and specialty auto-injectors across multiple therapeutic domains. This delivery order exemplifies the company's ongoing strategic partnership with DLA in fulfilling specialized medical supply requirements for federal military and healthcare operations.
Quick answers
Who was awarded contract SPE2DR26FQR4H?
SPE2DR26FQR4H was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 4, 2025.
How much is contract SPE2DR26FQR4H worth?
The government has obligated $31,461 on SPE2DR26FQR4H.
Is contract SPE2DR26FQR4H an order under another contract?
Yes. SPE2DR26FQR4H is a delivery order under SPE2DR25D1022, an indefinite delivery contract.
Was contract SPE2DR26FQR4H competed?
The extent of competition for SPE2DR26FQR4H was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award